z-logo
Premium
Correspondence of 25‐hepcidin concentrations by ELISA and mass spectrometric methods and their discrimination across healthy and ill subject groups
Author(s) -
Orozco Monica,
Arriaga Claudia Lorena,
Solomons Noel W.,
Schümann Klaus
Publication year - 2017
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.31.1_supplement.786.22
Subject(s) - hepcidin , context (archaeology) , biomarker , chemistry , medicine , inflammation , biology , biochemistry , paleontology
Background Increasing use of hepcidin as a biomarker of iron homeostasis, especially during infection and inflammation and other iron‐related disorders, calls for affordable and convenient assessment methods capable of precisely quantifying a wide range of hepcidin concentrations. Objective To evaluate two different versions of a commercial competitive enzyme‐linked immunosorbent assay (ELISA) kit for bioactive hepcidin‐25 quantitation, with similar dynamic ranges but different specificities, within a large range of hepcidin concentrations. Methods Plasma samples from 8 apparently healthy adults recruited in Sololá, Guatemala; 8 mildly sick patients attending clinical consultation at Sololá's National Hospital, and 8 end‐stage renal failure juvenile patients undergoing hemodialysis in FUNDANIER, Guatemala City, were collected to represent the widest possible range of continuous hepcidin concentrations in a human context: low (LH), middle (MH) and high (HH) levels. Hepcidin‐25 was quantified with two ELISA kits (DRG® EIA‐5258 & EIA‐5782) and the gold standard weak cation exchange time‐of‐flight mass‐spectrometry (TOFMS) method. Pearson product‐moment correlation coefficient test was applied to the 3 data‐sets to assess statistical dependence between the 3 methods to determine validity and repeatability. Results Average hepcidin concentrations (ng/ml) for LH subjects were: 9±5, 10±2, and 155±67; for MH patients: 29±12, 20±11, and 437±283; and for HH patients: 145±130, 212±295, and 3380±3486, with the TOFMS, EIA‐5258, and EIA‐5782 methods, respectively. Pearson rank correlation coefficients between TOFMS & EIA‐5258 and TOFMS & EIA‐5782 (validity) were 0.94 and 0.123, respectively, and between EIA‐5258 & ‐5782 (repeatability), 0.061. Conclusion Despite the declared improved specificity of the newest version of the kit (EIA‐5782), the older version (EIA‐5258) revealed a higher validity when compared to the gold standard, making it a better option for the assessment of a wide range of hepcidin concentrations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom